This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Best Growth Stocks to Buy for June 4th
by Zacks Equity Research
JNPR, EHC and UIS made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 4, 2025.
Best Growth Stocks to Buy for June 2nd
by Zacks Equity Research
EHC, CRMT and PVH made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 2, 2025
Encompass Health Corporation (EHC) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Encompass Health (EHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Best Growth Stocks to Buy for May 29th
by Zacks Equity Research
EHC, JNPR and EWCZ made it to the Zacks Rank #1 (Strong Buy) growth stocks list on May 29, 2025.
Here's Why Encompass Health Shares Are Attracting Investors Now
by Zacks Equity Research
EHC stock jumps 28.8% YTD as investors rally behind strong earnings beat, raised 2025 guidance and a growing national rehab hospital footprint.
Best Growth Stocks to Buy for May 27th
by Zacks Equity Research
EHC, GLDD and ODP made it to the Zacks Rank #1 (Strong Buy) growth stocks list on May 27, 2025
CI's Unit Unveils Offering to Expand Access to GLP-1 Medications
by Zacks Equity Research
Cigna's Evernorth business caps GLP-1 drug copays at $200 or less, aiming to boost affordability for patients and cut costs for health plan sponsors.
Brookdale Shares Down 4.9% Despite Q1 Earnings Meeting Estimates
by Zacks Equity Research
BKD continues to witness growth in revenue per available unit (RevPAR). It increases its EBITDA range for 2025.
EHC Opens Rehabilitation Unit in Fort Myers, Boosts Florida Footprint
by Zacks Equity Research
Encompass Health inaugurates the Rehabilitation Hospital of Fort Myers in partnership with Lee Health to provide high-quality rehabilitation services across Florida.
Best Growth Stocks to Buy for May 21st
by Zacks Equity Research
GLDD, EHC and UIS made it to the Zacks Rank #1 (Strong Buy) growth stocks list on May 21, 2025.
Factors That Make Centene Stock a Lucrative Pick Right Now
by Zacks Equity Research
CNC remains well-poised for growth on improved premiums, a well-performing Commercial Marketplace business, strategic divestitures and sound cash reserves.
4 Stocks Showing Strong Relative Price Strength Right Now
by Nilanjan Choudhury
GLDD, SFM, EVER and EHC are four stocks with explosive relative price strength.
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Best Growth Stocks to Buy for May 19th
by Zacks Equity Research
GLDD, EHC and UIS made it to the Zacks Rank #1 (Strong Buy) growth stocks list on May 19, 2025.
Encompass Health Corporation (EHC) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Encompass Health (EHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Best Growth Stocks to Buy for May 15th
by Zacks Equity Research
EHC, GLDD and BSAC made it to the Zacks Rank #1 (Strong Buy) growth stocks list on May 15, 2025.
The Joint Misses Q1 Earnings Estimates on Rising Expenses
by Zacks Equity Research
JYNT expects to open 30-40 franchised clinics in 2025, down from 57 last year.
Acadia Healthcare Q1 Earnings Top Estimates on Rising Admissions
by Zacks Equity Research
ACHC continues to witness growth in patient days. It authorizes a share repurchase program of almost $300 million.
Encompass Health to Expand Florida Presence With New 50-bed Facility
by Zacks Equity Research
EHC already boasts a massive footprint of 167 hospitals in 38 states and Puerto Rico.
Will Rising Expenses Hurt Acadia Healthcare's Q1 Earnings?
by Zacks Equity Research
ACHC's first-quarter results are likely to reflect benefits from growing revenue per patient day.
Encompass Health (EHC) Upgraded to Strong Buy: Here's Why
by Zacks Equity Research
Encompass Health (EHC) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Here's Why Encompass Health (EHC) is a Strong Growth Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Are You Looking for a Top Momentum Pick? Why Encompass Health (EHC) is a Great Choice
by Zacks Equity Research
Does Encompass Health (EHC) have what it takes to be a top stock pick for momentum investors? Let's find out.
Can Lower Expenses Save Pediatrix Medical's Q1 Earnings?
by Zacks Equity Research
MD's first-quarter results are likely to reflect declining hospital contract administrative fees.